ECMO for COVID-19 vs Influenza A H1N1 Associated ARDS (InfluCOV_ECMO)

University of Turin

Status: Completed

Conditions: COVID-19; ARDS; H1N1 Influenza

Study type: Observational

Funder types: Other

Identifiers

NCT05080933

v1_12_2020

Details and patient eligibility

About

Objective: Veno-venous ECMO has been used as a rescue therapy for patients with severe ARDS associated to influenza A H1N1 and COVID19 viral pneumonia. Little is known about outcome of these patients who required extracorporeal support.

Research question: To compare outcome of patients who required VV ECMO for Covid19 and H1N1 associated ARDS

Enrollment: 308 patients

Sex: All

Ages: 18 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• COVID-19 or influenza A H1N1 (suspected or confirmed) diagnosis
• Severe ARDS (according to Berlin Definition)
• VV ECMO
• Invasive mechanical ventilation through endotracheal tube or tracheostomy

Exclusion criteria

• Age<18 years

Trial design

308 participants in 2 patient groups

COVID-19

H1N1